IRIS UniCatt

Ciccarelli, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.843
NA - Nord America 3.433
AS - Asia 2.295
SA - Sud America 457
AF - Africa 94
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 10.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.293
DE - Germania 1.049
SG - Singapore 1.046
IT - Italia 739
CN - Cina 482
FR - Francia 436
SE - Svezia 411
BR - Brasile 379
PL - Polonia 287
GB - Regno Unito 264
VN - Vietnam 169
UA - Ucraina 142
IE - Irlanda 119
IN - India 112
FI - Finlandia 73
ID - Indonesia 73
CA - Canada 72
HK - Hong Kong 66
ES - Italia 60
JP - Giappone 56
KR - Corea 55
RU - Federazione Russa 48
AU - Australia 41
MX - Messico 41
TR - Turchia 38
AR - Argentina 37
BD - Bangladesh 35
PT - Portogallo 35
BE - Belgio 32
ZA - Sudafrica 29
NL - Olanda 28
AT - Austria 25
IQ - Iraq 22
IR - Iran 18
CI - Costa d'Avorio 17
PH - Filippine 17
PK - Pakistan 14
GR - Grecia 12
RO - Romania 12
CZ - Repubblica Ceca 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
VE - Venezuela 11
CH - Svizzera 10
NO - Norvegia 9
CM - Camerun 8
CO - Colombia 8
TW - Taiwan 8
JM - Giamaica 7
MA - Marocco 7
NG - Nigeria 7
NZ - Nuova Zelanda 7
DO - Repubblica Dominicana 6
EG - Egitto 6
HR - Croazia 6
JO - Giordania 6
MY - Malesia 6
QA - Qatar 6
TH - Thailandia 6
AL - Albania 5
CL - Cile 5
EC - Ecuador 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MM - Myanmar 2
PA - Panama 2
PY - Paraguay 2
SM - San Marino 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
Totale 10.158
Salva come PNG Salva come JPEG
Città #
Singapore 564
Chandler 472
Ashburn 285
Kraków 263
San Jose 228
Milan 154
New York 151
Jacksonville 122
Dublin 116
San Mateo 102
Beijing 99
Ann Arbor 83
Los Angeles 80
Cattolica 77
Lauterbourg 66
Nanjing 65
Jakarta 62
Ho Chi Minh City 58
Nürnberg 58
Dearborn 54
Redwood City 52
Boston 49
Hong Kong 49
The Dalles 47
Tokyo 47
Wilmington 47
Houston 46
Dallas 40
Rome 39
Woodbridge 39
Hanoi 37
Paris 37
Frankfurt am Main 36
Helsinki 35
Hefei 34
Redmond 34
Chicago 33
London 31
Lawrence 28
Princeton 28
São Paulo 28
Brussels 26
Santa Clara 25
Seattle 25
Ottawa 24
Izmir 23
Lancaster 23
Munich 23
Orem 23
Moscow 22
Buffalo 21
Augusta 19
Marseille 19
Montreal 19
Nanchang 19
Manchester 16
Mountain View 16
Rio de Janeiro 16
Warsaw 16
Abidjan 15
Fairfield 15
Johannesburg 15
Poplar 15
Shenyang 15
Toronto 15
Vienna 15
Amsterdam 14
Bremen 14
Catania 14
Norwalk 14
Changsha 13
Hyderabad 13
Leawood 13
Madrid 13
Turin 13
Council Bluffs 12
Seoul 12
St Louis 12
Atlanta 11
Boardman 11
Denver 11
Guangzhou 11
Brasília 10
Brescia 10
Cantù 10
Chennai 10
Da Nang 10
Florence 10
Glasgow 10
Kunming 10
Brooklyn 9
Haiphong 9
Melbourne 9
San Francisco 9
Tashkent 9
Andover 8
Cambridge 8
Capua 8
Hebei 8
Jiaxing 8
Totale 4.821
Salva come PNG Salva come JPEG
Nome #
The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study 506
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 365
OXFORD COGNITIVE SCREEN (OCS) FEASIBILITY IN THE STROKE UNIT SETTING 364
Narrative discourse in logopenic variant of PPA: a multi-level approach 304
Semantic memory in Object Use 290
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 267
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 253
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 221
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 218
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 217
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 214
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 210
AN ATTEMPT TO LOOK FOR DIFFERENCE BETWEEN DEGENERATIVE AND VASCULAR APHASIA: A DATA-DRIVEN CLUSTER ANALYSIS. 204
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 201
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 199
POST-STROKE QUALITY OF LIFE AND COGNITIVE FUNCTIONING: A LONGITUDINAL STUDY 195
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 194
Primary progressive aphasia: linguistic patterns and clinical variants 190
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 184
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 184
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 183
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 175
Unilateral Spatial Neglect in Degenerative Brain Pathology 167
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 166
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 163
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 158
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 157
Cognitive reserve and neuropsychological functioning in older HIV-infected people 156
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 154
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 154
The facial emotion recognition deficit in Parkinson's disease: Implications of a visual scanning strategy 149
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. 148
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 148
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 146
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 146
Effect of aging and human immunodeficiency virus infection on cognitive abilities 144
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 141
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 138
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 137
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 137
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 137
Posterior AD-type pathology: cognitive subtypes emerging from a cluster analysis 136
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 136
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 135
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 131
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 129
Degenerative and Vascular Fluent Aphasia: Looking for Differences 121
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 120
Writing errors in primary progressive aphasia 116
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 114
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 108
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 106
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 101
Cognitive reserve: a multidimensional protective factor in Parkinson's disease related cognitive impairment 100
Liver fibrosis is associated with cognitive impairment in people living with HIV 93
Writing errors in primary progressive aphasia 87
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 86
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 86
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 84
HIV 81
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 74
Totale 10.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021144 0 0 0 0 0 0 0 0 0 53 72 19
2021/2022679 51 40 21 90 32 30 30 111 23 51 67 133
2022/20231.439 167 205 77 213 90 153 77 136 179 37 74 31
2023/2024939 43 172 38 60 59 194 64 52 41 46 96 74
2024/20251.552 28 53 195 78 161 57 106 80 212 120 256 206
2025/20262.717 442 62 154 336 557 153 521 138 186 168 0 0
Totale 10.328